Ariel Fernández, the protein researcher whose theories of drug design lately have come in for questioning, has lost a paper, at least for the moment.
The article, “Supramolecular Evolution of Protein Organization,” appeared online in Annual Reviews of Genetics prior to print. It lists Fernández’s affiliation as ProWD Sciences, in Madison, Wisc. Not much exists on the web about that company, however, except an under-construction site. (ProWD, by the way, is short for PROtein-Water-Dehydron, Fernández’s area of interest.)
Here’s the notice:
It has come to our attention that some key concepts reviewed in the manuscript entitled “Supramolecular Evolution of Protein Organization” by Ariel Fernández derive from at least one article in the primary research literature currently under dispute due to unsettled anomalies in the data and/or interpretation. Annual Reviews, with concurrence of the review’s author, has decided to withhold final publication pending satisfactory resolution.
Fernández threatened to sue us when we wrote about an expression of concern for one of his articles.